quinoxalines has been researched along with acrylamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Durnev, AD; Nesterova, EV; Seredenin, SB | 1 |
| Abramsson-Zetterberg, L; Durling, LJ | 1 |
| Arlt, VM; Chepelev, NL; Cox, JA; Hölzl-Armstrong, L; Long, AS; Nævisdal, A; Phillips, DH; White, PA | 1 |
3 other study(ies) available for quinoxalines and acrylamide
| Article | Year |
|---|---|
Verapamil contributes to the clastogenic effects of acrylamide, cyclophosphamide, and dioxidine on somatic cells of BALB/C and C57BL/6 mice.
Topics: Acrylamide; Animals; Bone Marrow Cells; Calcium Channel Blockers; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutagens; Quinoxalines; Verapamil | 1999 |
A comparison of genotoxicity between three common heterocyclic amines and acrylamide.
Topics: Acrylamide; Animals; Dose-Response Relationship, Drug; Erythrocytes; Heterocyclic Compounds; Imidazoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Micronuclei, Chromosome-Defective; Mutagens; Quinolines; Quinoxalines; Structure-Activity Relationship | 2005 |
In vitro mutagenicity of selected environmental carcinogens and their metabolites in MutaMouse FE1 lung epithelial cells.
Topics: Acrylamide; Animals; Carcinogens, Environmental; Cell Line; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2E1; Epithelial Cells; Gene Expression Regulation; Humans; Imidazoles; Lung; Metabolome; Mice; Mutagenesis; Mutagenicity Tests; Quinoxalines | 2020 |